We've found
8,147
archived clinical trials in
Asthma
We've found
8,147
archived clinical trials in
Asthma
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Updated: 4/30/2013
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy
Status: Enrolling
Updated: 4/30/2013
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Updated: 4/30/2013
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Updated: 4/30/2013
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy
Status: Enrolling
Updated: 4/30/2013
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Updated: 4/30/2013
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Updated: 4/30/2013
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy
Status: Enrolling
Updated: 4/30/2013
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Updated: 4/30/2013
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fluticasone Propionate DPI Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Persistent Asthma Uncontrolled on Non-steroidal Therapy
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Updated: 4/30/2013
A Six-Period Crossover, Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of FS Spiromax (Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder) Administered as Single Doses Compared With Single Doses of Fluticasone Propionate Spiromax and Open Label Advair Diskus in Adult and Adolescent Subjects With Persistent Asthma
Status: Enrolling
Updated: 4/30/2013
Click here to add this to my saved trials
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens
Updated: 5/2/2013
Feasibility of an ED-initiated Online Asthma Management Program for Urban Teens (Puff City-ED)
Status: Enrolling
Updated: 5/2/2013
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens
Updated: 5/2/2013
Feasibility of an ED-initiated Online Asthma Management Program for Urban Teens (Puff City-ED)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens
Updated: 5/2/2013
Feasibility of an ED-initiated Online Asthma Management Program for Urban Teens (Puff City-ED)
Status: Enrolling
Updated: 5/2/2013
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens
Updated: 5/2/2013
Feasibility of an ED-initiated Online Asthma Management Program for Urban Teens (Puff City-ED)
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
Updated: 5/13/2013
Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
Status: Enrolling
Updated: 5/13/2013
Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
Updated: 5/13/2013
Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
Status: Enrolling
Updated: 5/13/2013
Click here to add this to my saved trials
Exercise-Induced Bronchospasm in Cystic Fibrosis
Updated: 5/13/2013
Exercise-Induced Bronchospasm in Cystic Fibrosis
Status: Enrolling
Updated: 5/13/2013
Exercise-Induced Bronchospasm in Cystic Fibrosis
Updated: 5/13/2013
Exercise-Induced Bronchospasm in Cystic Fibrosis
Status: Enrolling
Updated: 5/13/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
Updated: 5/17/2013
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Status: Enrolling
Updated: 5/17/2013
Click here to add this to my saved trials
Evaluation of a Shared Decision Making Portal for Pediatric Asthma
Updated: 6/3/2013
Evaluation of a Shared Decision Making Portal for Pediatric Asthma
Status: Enrolling
Updated: 6/3/2013
Evaluation of a Shared Decision Making Portal for Pediatric Asthma
Updated: 6/3/2013
Evaluation of a Shared Decision Making Portal for Pediatric Asthma
Status: Enrolling
Updated: 6/3/2013
Click here to add this to my saved trials
Use of a Probiotic Supplement to Prevent Asthma in Infants
Updated: 6/11/2013
Trial of Infant Probiotic Supplementation to Prevent Asthma
Status: Enrolling
Updated: 6/11/2013
Use of a Probiotic Supplement to Prevent Asthma in Infants
Updated: 6/11/2013
Trial of Infant Probiotic Supplementation to Prevent Asthma
Status: Enrolling
Updated: 6/11/2013
Click here to add this to my saved trials
Using Mobile Phones to Improve Adherence to Inhaled Steroids
Updated: 6/19/2013
Refined ADEPT: Human Augmentics for Sustained Wellbeing
Status: Enrolling
Updated: 6/19/2013
Using Mobile Phones to Improve Adherence to Inhaled Steroids
Updated: 6/19/2013
Refined ADEPT: Human Augmentics for Sustained Wellbeing
Status: Enrolling
Updated: 6/19/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Updated: 6/27/2013
A Prospective, Open-Label Assessment of the Albuterol Spiromax® DPI Integrated Dose Counter
Status: Enrolling
Updated: 6/27/2013
Click here to add this to my saved trials